- ►annals.org [PDF] DA Ahlquist, DJ Sargent, CL Loprinzi, TR … - Annals of Internal Medicine, 2008 - Am Coll Physicians David A. Ahlquist, MD; Daniel J. Sargent, PhD; Charles L. Loprinzi, MD; Theodore
R. Levin, MD; Douglas K. Rex, MD; Dennis J. Ahnen, MD; Kandice Knigge, MD; M.
Peter Lance, MD; Lawrence J. Burgart, MD; Stanley R. Hamilton, MD; James E. ... Cited by 22 - Related articles - All 5 versions
H Zou, WR Taylor, JJ Harrington, FTN Hussain … - Gastroenterology, 2009 - Elsevier We combined a melt curve assay with digital polymerase chain reaction and
validated the quantitative range. We then evaluated its ability to detect
neoplasms in 2 clinical studies. In study I, stool samples from patients ... Cited by 9 - Related articles - All 3 versions
F Diehl, K Schmidt, KH Durkee, KJ Moore, SN … - Gastroenterology, 2008 - Elsevier Background & Aims: Somatic mutations provide uniquely specific markers for the
early detection of neoplasia that can be detected in DNA purified from plasma or
stool of patients with colorectal cancer. The primary purpose of the ... Cited by 19 - Related articles - All 3 versions
[CITATION] Stool DNA and Occult Blood Testing for Screen Detection of Colorectal Neoplasia.
- ►oxfordjournals.org V Melotte, MHFM Lentjes, SM van den Bosch, … - JNCI Journal of the National Cancer Institute, 2009 - jnci.oxfordjournals.org Methods: NDRG4 promoter methylation was analyzed in human colorectal cancer cell
lines, colorectal tissue, and noncancerous colon mucosa by using
methylation-specific polymerase chain reaction (PCR) and bisulfite ... Cited by 3 - Related articles - All 4 versions
- ►oxfordjournals.org JE Allison, LC Sakoda, TR Levin, JP Tucker, … - JNCI Journal of the National Cancer Institute, 2007 - jnci.oxfordjournals.org Methods: We assessed prospectively the performance characteristics of two newer
FOBTs in 5841 subjects at average risk for colorectal cancer in a large
group–model managed care organization. The tests evaluated included a ... Cited by 48 - Related articles - BL Direct - All 8 versions
SH Itzkowitz, L Jandorf, R Brand, L Rabeneck … - Clinical Gastroenterology and Hepatology, 2007 - Elsevier Background & Aims: Fecal DNA testing has shown greater sensitivity than
guaiac-based occult blood tests for noninvasive colorectal cancer (CRC)
screening. The prototype assay (version 1), which analyzed 22 gene ... Cited by 75 - Related articles - All 15 versions
- ►annals.org NN Baxter, MA Goldwasser, LF Paszat, R … - Annals of Internal Medicine, 2009 - Am Coll Physicians Background: Colonoscopy is advocated for screening and prevention of colorectal
cancer (CRC), but randomized trials supporting the benefit of this practice are
not available. ... Objective: To evaluate the association between ... Cited by 40 - Related articles - All 11 versions
EP Whitlock, JS Lin, E Liles, TL Beil, R Fu - Annals of Internal Medicine, 2008 - Am Coll Physicians Background: In 2002, the US Preventive Services Task Force (USPSTF) recommended
colorectal cancer screening for adults 50 years of age or older but concluded
that evidence was insufficient to prioritize among screening tests or ... Cited by 32 - Related articles - All 5 versions
S Itzkowitz, R Brand, L Jandorf, K Durkee, J … - Am J Gastroenterol, 2008 - phx1.medscape.com To test the performance of the version 2 assay for CRC, we conducted a two-phase
study. The study was designed to use the version 2 assay to analyze two sets of
patients with sDNA from CRC patients and those with NC. The first set ... Cited by 5 - Related articles - All 11 versions
